Last reviewed · How we verify
NCT04939181
Non-invasive Neuromodulation NESA in Neuroefficiency in Basketball Players
NA trial testing Non-invasive Neuromodulation in Basketball Player in 12 participants. Completed in 18 November 2021.
30 September 2021
Quick facts
| Lead sponsor | University of Las Palmas de Gran Canaria |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | supportive care |
| Enrollment | 12 |
| Start date | 1 May 2021 |
| Primary completion | 30 September 2021 |
| Estimated completion | 18 November 2021 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Non-invasive Neuromodulation
- Placebo Non-invasive Neuromodulation
Conditions studied
- Basketball Player — all drugs for Basketball Player →
Sponsor
University of Las Palmas de Gran Canaria
Who can join
Adults 18 to 24, male only, with Basketball Player. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Competitive team sports calendars are becoming increasingly compressed, generating changes in the effort-recovery cycle. Given this new situation, it seems necessary to analyze how it affects the physiological and performance level of semi-professional players, as well as how to observe if the non-invasive neuromodulation technique NESA helps the neuroefficiency and concentration values of said players.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Recovery of the physiological status in professional basketball players using NESA neuromodulation treatment during different types of microcycles in season: A preliminary randomized clinical trial.
García F, Fernández D, Vázquez-Guerrero J, Font R, et al · · 2022 · cited 5× · PMID 36483295 · DOI 10.3389/fphys.2022.1032020
Verify or expand the search:
- PubMed search for NCT04939181
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Non-invasive Neuromodulation
Trials testing the same drug.
- NCT04962737 — Non-invasive Neuromodulation NESA Through Somatosensory Evoked Potentials and Sympathetic-cutaneous Responses · NA · not yet recruiting
- NCT06417450 — Usefulness of NESA Microcurrents in the Treatment of Children With Autism Spectrum Disorders · NA · completed
- NCT06288061 — Effectiveness of Non-invasive Phrenic Nerve Neuromodulation in Subjects With Inflammatory Bowel Disease and Neck Pain. · NA · completed
- NCT06230679 — Effectiveness of NESA in the Treatment of Cancer Survivors · NA · completed
- NCT06134999 — Study of Patients With Knee Prostheses Treated With Noninvasive Neuromodulation · NA · completed
Other University of Las Palmas de Gran Canaria trials
Trials by the same sponsor.
- NCT04962737 — Non-invasive Neuromodulation NESA Through Somatosensory Evoked Potentials and Sympathetic-cutaneous Responses · NA · not yet recruiting
- NCT06417450 — Usefulness of NESA Microcurrents in the Treatment of Children With Autism Spectrum Disorders · NA · completed
- NCT06134999 — Study of Patients With Knee Prostheses Treated With Noninvasive Neuromodulation · NA · completed
- NCT06138158 — Improvement of Fear-avoidance Beliefs in Patients With Chronic Low Back Pain · NA · completed
- NCT05800431 — NESA Microcurrents on Quality of Life in Geriatric Patients · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04939181 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Las Palmas de Gran Canaria
- Last refreshed: 14 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04939181.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing